Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 119   

Articles published

MDT 63.60 +0.08 (0.13%)
price chart
Medtronic Spends $350M on Another European Deal
Medtronic Inc., which makes pacemakers, insulin pumps and other devices, is part of a wave of U.S. companies considering or putting together tax-lowering overseas deals known as inversions that are drawing growing scrutiny from U.S.
Medtronic buying hospital services firm NGC Medical  Minneapolis / St. Paul Business Journal
Medtronic Acquires Sapiens Steering Brain Stimulation  MarketWatch
Related articles »  
Medtronic Shareholders Against Covidien Acquisition
Medtronic, Inc. (MDT) CEO Omer Ishak faced disapproval from shareholders in an annual shareholder meeting held Thursday.
Obama may not like Medtronic-Covidien deal, but these people really hate it  Minneapolis / St. Paul Business Journal
Covidien acquires California company  Boston Globe
Related articles »  
Medtronic, Inc. Stock Earnings: 3 Key Takeaways
Medtronic (NYSE: MDT ) just reported its earnings for the first quarter of fiscal 2015, topping analyst estimates on both the top and bottom lines.
Upset stockholders confront Medtronic executives  Minneapolis Star Tribune
Medtronic CEO says Covidien deal good for US economy  Reuters
Related articles »  
Medtronic Viva CRT-P Therapy-Pacemaker Gets FDA Green Signal
Medtronic, Inc. (MDT) announced that the US Food and Drug Administration (FDA) has approved its cardiac resynchronization therapy-pacemaker - Viva� CRT-P - for patients suffering from heart failure or atrioventicular (AV) blockage.
Medtronic Unveils Viva CRT-P for Heart Failure Therapy in US  Zacks.com
Medtronic Viva(R) Cardiac Resynchronization Therapy-Pacemaker Now ...  MarketWatch
Related articles »  
Medtronic Inc.: Medtronic Acquires NGC Medical to Strengthen Its Integrated ...
TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.
Related articles »  
Medtronic buys Sapiens SBS for $200M
Medtronic Inc. said Tuesday that it is paying $200 million in cash for a Dutch company that is working on a next-generation deep-brain stimulation device for patients with neurodegenerative diseases.
Medtronic hires ex-senators to lobby bills that could kill Covidien deal
WASHINGTON - Medtronic Inc. has hired two former U.S. senators to lobby their ex-colleagues against legislation that could undermine the company's plans to move its headquarters overseas through a merger, saving it billions in taxes.
Covidien Faces New Investor Suit Over $43B Medtronic Deal  Law360 (subscription)
Covidien PLC - 11.6% Upside: Out Of The Gate, Too Late To Catch  Seeking Alpha (registration)
Related articles »  
Medtronic defends tax inversion strategy
With the company facing a backlash over its strategy, Medtronic Inc. CEO Omar Ishrak last week defended its plan to merge with an Irish company and move its official headquarters overseas.
5 Things Medtronic, Inc.'s Management Wants You to Know  Motley Fool
Related articles »  
Medtronic pays $200 million for brain-stimulation tech
Medtronic Inc. said Tuesday it had bought Sapiens Steering Brain Stimulation, a Dutch maker of a tool that can send electrical pulses deep inside the brain.
Medtronic Buys Brain-Stimulation Firm
The deal comes as Medtronic pursues the completion of its $42.9 billion deal to buy Covidien PLC (COV), which has come under scrutiny over a tax tactic called inversion that has drawn criticism from U.S.